SAINT LUKES HOSPITAL OF KANSAS CITY
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $53M
- Transactions
- 4,484
- Companies
- 40
- Average per transaction
- $11,827
Who reported the payments
| AstraZeneca | $16,631,929 |
| Pfizer | $6,789,957 |
| Boston Scientific | $3,617,947 |
| Seagen Inc. | $3,497,674 |
| Edwards Lifesciences | $3,396,797 |
| Novartis | $3,221,623 |
| Boehringer Ingelheim | $2,139,332 |
| Abbott | $1,970,862 |
| E.r. Squibb & Sons, L.L.C. | $798,350 |
| Cochlear Americas | $794,550 |
| Merck | $672,125 |
| AbbVie | $615,153 |
| Shockwave Medical, Inc | $510,831 |
| Astrazeneca UK Limited | $504,674 |
| Medtronic | $476,648 |
| Janssen Research & Development, LLC | $475,033 |
| Incyte Corporation | $421,569 |
| Janssen Scientific Affairs, LLC | $381,881 |
| Vifor (international) Ltd. | $376,585 |
| Abiomed | $310,183 |
| Inari Medical, Inc. | $297,307 |
| Daiichi Sankyo Inc. | $291,632 |
| Sanofi US Services Inc. | $284,125 |
| Genentech, Inc. | $270,507 |
| Cardiovascular Systems Inc. | $222,150 |
| Novo Nordisk AS | $220,933 |
| Asahi Intecc USA, Inc. | $218,256 |
| Atricure, Inc. | $207,313 |
| Tesaro, Inc. | $173,429 |
| Recor Medical Inc | $165,776 |
| United Therapeutics Corporation | $161,744 |
| Exelixis Inc. | $145,430 |
| Zimmer Biomet | $131,888 |
| Siemens Medical Solutions USA, Inc. | $131,494 |
| Lexicon Pharmaceuticals, Inc. | $131,250 |
| Terumo Medical Corporation | $130,000 |
| Medical Device Business Services, Inc. | $123,836 |
| Gilead | $116,474 |
| Davol Inc. | $111,987 |
| Endotronix, Inc. | $108,758 |